Daslemia 100mg 30 Tablets

babies: it s not applicable for babies. lactating mothers: it is unsafe to use in breastfeeding.
limited human studies and animal studies showed that drug causes harmful effects on the developing babies. pregnancy: it is unsafe to use in pregnancy.
limited human studies and animal studies showed that drug causes harmful effects on the fetus. consult your doctor before using this medicine.
driving: it is unsafe to drive after taking this medication. alcohol: information about the effects of this medication on alcohol is limited. consult your doctor. liver: it is safe to use this medication in liver disease patients.
you may not require any dose adjustments. consult your doctor before using this medication. kidney: it is safe to use this medication in kidney disease patients.
you may not require any dose adjustments. consult your doctor before using this medication..

nausea vomiting loss of appetite decreased blood cells rashes.

daslemia tablet is an antineoplastic agent. it controls the proliferation and spread of cancer cells.
it blocks the proteins that are essential to the cancer cells for their growth..

if you miss a dose, take it as soon as possible. if it is near the time of the next dose, then skip the missed dose.
take the prescribed dose on your regular time daily. don't double the dose to catch up with the missed dose..

• take this medication as directed by your doctor. • avoid taking excess doses of this medication. • store the medication properly.
• do not discontinue the treatment course though you feel better. • inform your doctor if you develop skin rashes after taking this medication.
• do not drive if you develop dizziness or sleepiness after taking this medication. • do not freeze the medication.
.

major • daslemia+ bcg vaccine: concurrent use of these drugs may increase the risk for the development of the infection • daslemia+ adalimumab: concurrent use of these drugs may increase the risk for the development of the infection • daslemia + cladribine: concurrent use of these drugs may increase the risk for the development of infection • daslemia + clozapine: concurrent use of these drugs may increase the risk of bone marrow dysfunction • daslemia + daunorubicin: concurrent use of these drugs may increase the risk of developing heart problems • daslemia + golimumab: concurrent use of these drugs may increase the risk of side effects • daslemia + influenza virus vaccine, live: concurrent use of these drugs may increase the risk of developing an infection moderate • daslemia + anakinra: concurrent use of these drugs may increase the risk for the development of infections • daslemia + azathioprine: concurrent use of these drugs may increase the risk for the development of infection • daslemia + chloramphenicol: concurrent use of these drugs may increase the blood levels of chloramphenicol.